BJDX Stock Analysis: Buy, Sell, or Hold?
BJDX - Bluejay Diagnostics, Inc. Common Stock
$1.14
-0.06 (-5.00%)
βΌ
5d:
-65.56%
30d:
-73.73%
90d:
-39.68%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When BJDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: BJDX is down 65.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: BJDX is down 65.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BJDX is currently trading at $1.14, which is considered oversold relative to its 30-day fair value range of $2.29 to $4.86.
Technical Outlook: Technically, BJDX is in a uptrend. Immediate support is located at $1.03, while resistance sits at $4.86. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $256.00 (+22356.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BJDX is in a uptrend. Immediate support is located at $1.03, while resistance sits at $4.86. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $256.00 (+22356.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.29 -
$4.86
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.0%)
- BULLISH: Trading 22356.1% below Wall St target ($256.00)
- WARNING: Recommendation downgraded due to -65.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.29 -
$4.86
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.03
Resistance Level
$4.86
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Wall Street Target
$256.00
(+22356.1%)
Share & Embed Analysis
Last updated: July 02, 2026 10:43 PM ET
Data refreshes hourly during market hours. Next update: 11:43 PM
Data refreshes hourly during market hours. Next update: 11:43 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BJDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |